• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human CHMP6 Polyclonal Antibody

The antibody against CHMP6 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 111-200 of human CHMP6 (NP_078867.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

ADA-08787A

The antibody against CHMP6 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 111-200 of human CHMP6 (NP_078867.2) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IF/ICC, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-08787A ClonalityPolyclonal
Host SpeciesRabbitTarget NameCHMP6
Target SynonymsVPS20; CHMP6FormLiquid
Species ReactivityHuman, MouseIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.05% proclin300, pH7.3.Purification MethodAffinity purification
Positive SamplesJurkat, PC-3, U2OSApplicationELISA, WB, IF/ICC

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 111-200 of human CHMP6 (NP_078867.2).Target SpeciesHuman
Immunogen SequenceLNKMHQVMSIEEVERILDETQEAVEYQRQIDELLAGSFTQEDEDAILEELSAITQEQIELPEVPSEPLPEKIPENVPVKARPRQAELVAAUniprot IDQ96FZ7
Background Information
  • Uniprot Id

    Q96FZ7

  • Target Species

    Human

  • Target Name

    CHMP6

  • Target Full Name

    Charged multivesicular body protein 6

  • Target Function

    Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. In the ESCRT-III complex, it probably serves as an acceptor for the ESCRT-II complex on endosomal membranes.

  • Target Subcellular Location

    Endomembrane system. Endosome membrane; Lipid-anchor. Late endosome membrane. Membrane; Lipid-anchor. Note=Localizes to endosomal membranes.

  • Target Protein Families

    SNF7 family

  • Target Tissue Specificity

    Ubiquitously expressed.

  • Target Synonyms

    Charged multivesicular body protein 6; chmp6; CHMP6_HUMAN; Chromatin modifying protein 6; Chromatin-modifying protein 6; FLJ11749; hVps 20; hVps20; novel SNF7 protein; OTTMUSP00000004363; RGD1565325; RP24 225K18.4; Vacuolar protein sorting associated protein 20; Vacuolar protein sorting-associated protein 20; Vps 20; Vps20

  • Target Background

    This gene encodes a member of the chromatin-modifying protein/charged multivesicular body protein family. Proteins in this family are part of the ESCRT-III (endosomal sorting complex required for transport III) which degrades surface receptors, and in biosynthesis of endosomes.

Inquire Rabbit anti-Human CHMP6 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification